.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Harvard Business School
Argus Health
Medtronic
Novartis
Daiichi Sankyo
Johnson and Johnson
Mallinckrodt
Farmers Insurance
Chubb

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074686

« Back to Dashboard
NDA 074686 describes GLYBURIDE (MICRONIZED), which is a drug marketed by Sanofi Aventis Us, Sandoz, Teva, Hikma, Dava Pharms Inc, and Mylan, and is included in six NDAs. It is available from nine suppliers. Additional details are available on the GLYBURIDE (MICRONIZED) profile page.

The generic ingredient in GLYBURIDE (MICRONIZED) is glyburide. There are twenty drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the glyburide profile page.

Summary for NDA: 074686

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 074686

Ingredient-typeSulfonylurea Compounds

Suppliers and Packaging for NDA: 074686

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLYBURIDE (MICRONIZED)
glyburide
TABLET;ORAL 074686 ANDA Teva Pharmaceuticals USA Inc 0093-8034 0093-8034-01 100 TABLET in 1 BOTTLE (0093-8034-01)
GLYBURIDE (MICRONIZED)
glyburide
TABLET;ORAL 074686 ANDA Teva Pharmaceuticals USA Inc 0093-8035 0093-8035-01 100 TABLET in 1 BOTTLE (0093-8035-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.5MG
Approval Date:Apr 20, 1999TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG
Approval Date:Apr 20, 1999TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4.5MG
Approval Date:Apr 20, 1999TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Argus Health
Baxter
UBS
Colorcon
Cantor Fitzgerald
Express Scripts
Dow
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot